News | Cardiovascular Education | April 25, 2024

Heart-Valve-Surgery.Com, Medtronic Launch Novel 'Aortic Stenosis Patient Activation Platform' to Empower Patients

Aortic Stenosis Patient Activation Platform

April 25, 2024 —Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from Medtronic, a global leader in healthcare technology, launched the "Aortic Stenosis Patient Activation Platform", an end-to-end digital platform for patient awareness, patient education, and patient activation specific to aortic valve stenosis.

Aortic stenosis is a narrowing of the aortic valve which prevents the aortic leaflets from opening and closing properly.  As a result, the heart must work "over time" to pump blood throughout the body. Patients with aortic stenosis often have heart murmurs and experience debilitating symptoms including chest pain, dizziness, fatigue, shortness of breath and an irregular heartbeat. 

"Aortic stenosis is a deadly and under-treated disease," states Dr. Ashish Aneja, Director of Non-Invasive Cardiology at MetroHealth. Without treatment, up to 50% of patients will die 24 months after the onset of symptoms1. According to Dr. Kendra Grubb, Surgical Director of the Emory Structural Heart & Valve Center, approximately 40%† of patients with aortic stenosis in the United States do not get treatment because their symptoms are often misdiagnosed or ignored2.

Two common approaches for treating aortic stenosis include surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). During the past 10 years, there has been a significant increase in the use of TAVR for aortic stenosis as the estimated number of TAVR procedures performed per year in the United States has increased from 4,600 procedures in 2012 to over 100,000 procedures in 20233.

Because treatment continues to increase and evolve, the "Aortic Stenosis Patient Activation Platform", developed by Heart-Valve-Surgery.com with support from Medtronic and a world-renowned team of physicians, will increase awareness and education for aortic stenosis patients. The proprietary platform leverages artificial intelligence, patient-centric algorithms, geolocation strategies, next-generation telephony engines, robust patient databases, and a social media following of over 500,000 people.  

"Using an integrated system of proprietary digital building blocks, the Aortic Stenosis Patient Activation Platform helps patients establish real-time connections with fifty heart teams that specialize in aortic stenosis treatment," states Adam Pick, who started Heart-Valve-Surgery.com after having an aortic valve replacement in 2006.

"At Medtronic, we are committed to helping aortic stenosis patients benefit from durable, minimally invasive devices that consider the lifetime management of heart valve disease," stated Nina Goodheart, Senior Vice President and President, Structural Heart & Aortic, which is part of the Cardiovascular Portfolio at Medtronic. "We appreciate the opportunity to partner with Heart-Valve-Surgery.com and heart teams across the nation on this important initiative."

To experience the Aortic Stenosis Patient Activation Platform, please click here.

To explore the TAVR Heart Team Finder, please click here. 

To download the new eBook, "Medtronic TAVR Procedure: What 7 Facts Should Patients Know?", click here.

For more information: https://www.heart-valve-surgery.com/


Related Content

News | Cardiovascular Education

Feb. 14, 2026 — Cardiovascular Research Foundation (CRF) has announced the creation of Complex Coronary Summit, a new ...

Home February 19, 2026
Home
News | Cardiovascular Education

Feb. 3, 2026 — The first official summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI ...

Home February 04, 2026
Home
News | Cardiovascular Education

Nov. 12, 2025 — The Association of Black Cardiologists (ABC) has released new findings from a national survey exposing a ...

Home November 17, 2025
Home
News | Cardiovascular Education

June 30, 2025 — A new ESC Clinical Consensus Statement published in the European Heart Journal discusses the key role of ...

Home July 09, 2025
Home
News | Cardiovascular Education

May 15, 2025 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of ...

Home May 16, 2025
Home
News | Cardiovascular Education

The American Heart Association recently announced that Dr. Christine E. Seidman, an internationally renowned physician ...

Home May 02, 2025
Home
News | Cardiovascular Education

April 10, 2025 — The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative ...

Home April 10, 2025
Home
News | Cardiovascular Education

Feb. 10, 2025 — A generous gift of $5 million from Lorraine and Bill Dodero will establish the Lorraine and Bill Dodero ...

Home February 14, 2025
Home
News | Cardiovascular Education

Aug. 8, 2024 — Radiation from X-rays is an occupational hazard for many medical specialists, including cardiologists ...

Home August 08, 2024
Home
News | Cardiovascular Education

July 26, 2024 — VentriJect, a Danish medtech start-up seeking to revolutionize the way cardiorespiratory fitness (CRF) ...

Home July 26, 2024
Home
Subscribe Now